Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04832724 |
|---|---|
| Brief Title: | RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD) |
| First Submitted : | March 30, 2021 |
| First Submitted that Met QC Criteria : | April 1, 2021 |
| First Posted : | April 6, 2021 |
| Last Update Submitted that Met QC Criteria : | April 10, 2024 |
| Last Update Posted : | April 12, 2024 |